Complete Report is available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-greece.html . In 2012, Greece’s population was estimated at 11.4 million. The growth rate of the Greek population is decreasing steadily and this may be due to a negative balance between the mortality and birth rates, and low net rate of immigration. Greek policymakers are now presented with the problems of cost containment due to debt crisis, in addition to having a declining population of the working age group and an increasing elderly population. Greece’s pharmaceutical market was estimated to be worth $7.8 billion in 2012 and is expected to reach approximately $8.23 billion by 2020. The market in grew nominally at a Compound Annual Growth Rate (CAGR) of 0.6% from 2007 to 2012. The medical device market was worth approximately $970 million in 2012 and is expected to reach approximately $1.2 billion by 2020 at a projected CAGR of 3.7%. These positive trends can primarily be attributed to - • An increasing elderly population • Increasing awareness regarding early disease detection and diagnosis

1. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
Single User PDF: US$ 1995
Corporate User PDF: US$ 5985
Order this report by calling
+1 888 391 5441 or Send an email
to sales@marketoptimizer.org
with your contact details and
questions if any.
1

2. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
In 2012, Greece’s population was estimated at 11.4 million. The growth rate of
the Greek population is decreasing steadily and this may be due to a negative
balance between the mortality and birth rates, and low net rate of immigration.
Greek policymakers are now presented with the problems of cost containment
due to debt crisis, in addition to having a declining population of the working age
group and an increasing elderly population.
Greece’s pharmaceutical market was estimated to be worth $7.8 billion in 2012
and is expected to reach approximately $8.23 billion by 2020. The market in
grew nominally at a Compound Annual Growth Rate (CAGR) of 0.6% from 2007
to 2012. The medical device market was worth approximately $970 million in
2012 and is expected to reach approximately $1.2 billion by 2020 at a projected
CAGR of 3.7%. These positive trends can primarily be attributed to –
An increasing elderly population
Increasing awareness regarding early disease detection and diagnosis
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
2

3. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
Researcher, the industry analysis specialist, has released its latest report,
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Greece”.
The report is an essential source of information and analysis on the healthcare,
regulatory and reimbursement landscape in Greece. It identifies the key trends
in the healthcare market and provides insights into the demographic, regulatory,
reimbursement landscape and healthcare infrastructure. Most importantly, the
report provides valuable insights into the trends and segmentation of the
pharmaceutical and medical device markets. It is built using data and
information sourced from proprietary databases, secondary research, and in-
house analysis by Researcher’s team of industry experts.
Inquiry before buying this Report @
http://www.marketoptimizer.org/contacts/inquire-before-
buying?rname=2813 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
3

4. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
Scope
The report provides information on the healthcare, regulatory, and
reimbursement landscape in Greece, and includes -
An overview of the pharmaceutical and medical device markets, comprising
market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market
(Sanofi, Novartis, Pfizer, GlaxoSmithKline and Roche) and the medical device
market (Siemens Healthcare, F. Hoffmann-La Roche, Medtronic, Essilor
International and GlaxoSmithKline)
Insightful review of the reimbursement and regulatory landscape, of which
analysis includes details of the healthcare reimbursement process, the
regulatory agencies and the approval processes for new drugs and medical
devices
Complete Report is available @
http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-
reimbursement-landscape-greece.html .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
4

5. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
Develop business strategies by understanding the trends shaping and driving
Greece’s healthcare market.
Drive revenues by understanding the key trends, reimbursement and regulatory
policies, pharmaceutical market segments, and companies likely to impact the
healthcare market in the future.
Formulate effective sales and marketing strategies by understanding the
competitive landscape and analyzing the performance of various competitors.
Organize your sales and marketing efforts by identifying the market categories
and segments that present the most opportunities for consolidation, investment,
and strategic partnership
Buy the copy of this Report @
http://www.marketoptimizer.org/contacts/purchase?rname=2813 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
5

6. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – Greece
About Us
marketoptimizer.org is an online market research reports library of 250,000+ in-depth
studies of over 5000 micro markets. Our database includes reports by leading publishers
from across the globe. We provide 24/7 online and offline support service to our
customers. marketoptimizer.org also offers company data, country profiles, trends,
information and analysis on the sector of your interest.
Visit Us @
http://www.marketoptimizer.org
Follow Us:
Call Now + 1 888 391 5441 | Email sales @ sales@marketoptimizer.org
6